You know things aren’t where they need to be for a company when the CFO states it will be a “rebuilding year.” That’s the scenario for CVS Health (NYSE: CVS) in 2017.
The giant pharmacy services company announces its first-quarter results on May 2. Investors probably should have low expectations compared to CVS Health’s prior-year period performance. Here are seven reasons why.